DE60127442D1 - Verfahren der pibf-konzentrationsbestimmung zur diagnose eines tumors in einem patienten - Google Patents

Verfahren der pibf-konzentrationsbestimmung zur diagnose eines tumors in einem patienten

Info

Publication number
DE60127442D1
DE60127442D1 DE60127442T DE60127442T DE60127442D1 DE 60127442 D1 DE60127442 D1 DE 60127442D1 DE 60127442 T DE60127442 T DE 60127442T DE 60127442 T DE60127442 T DE 60127442T DE 60127442 D1 DE60127442 D1 DE 60127442D1
Authority
DE
Germany
Prior art keywords
pibf
patient
tumor
diagnosis
concentration determination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60127442T
Other languages
English (en)
Other versions
DE60127442T2 (de
Inventor
Julia Szekeres-Bartho
Eszter Nagy
Beata Polgar
Tamas Palkovics
Margit Koch
Christoph Klade
Tamas Henics
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Valneva Austria GmbH
Original Assignee
Intercell Austria AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intercell Austria AG filed Critical Intercell Austria AG
Application granted granted Critical
Publication of DE60127442D1 publication Critical patent/DE60127442D1/de
Publication of DE60127442T2 publication Critical patent/DE60127442T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4715—Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Reproductive Health (AREA)
  • Cell Biology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Microbiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE60127442T 2000-11-28 2001-11-28 Verfahren der pibf-konzentrationsbestimmung zur diagnose eines tumors in einem patienten Expired - Fee Related DE60127442T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AT0199700A AT410753B (de) 2000-11-28 2000-11-28 Pibf für die diagnose von tumoren
AT19972000 2000-11-28
PCT/EP2001/013876 WO2002044734A1 (en) 2000-11-28 2001-11-28 Method for diagnosing a tumor in a patient determining the concentration of pibf

Publications (2)

Publication Number Publication Date
DE60127442D1 true DE60127442D1 (de) 2007-05-03
DE60127442T2 DE60127442T2 (de) 2007-11-29

Family

ID=3689570

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60127442T Expired - Fee Related DE60127442T2 (de) 2000-11-28 2001-11-28 Verfahren der pibf-konzentrationsbestimmung zur diagnose eines tumors in einem patienten

Country Status (9)

Country Link
US (1) US20040142394A1 (de)
EP (1) EP1337850B1 (de)
JP (2) JP4025645B2 (de)
AT (2) AT410753B (de)
AU (2) AU2490102A (de)
CA (1) CA2431837A1 (de)
DE (1) DE60127442T2 (de)
ES (1) ES2283461T3 (de)
WO (1) WO2002044734A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATA8092002A (de) * 2002-05-28 2005-01-15 Intercell Ag Pibf
JP2015109806A (ja) * 2012-03-22 2015-06-18 アステラス製薬株式会社 新規ｒｅｔ融合体の検出法
GB201702392D0 (en) * 2017-02-14 2017-03-29 Univ Edinburgh Methods for cancer diagnosis using a gene expression signature
CN108447537A (zh) * 2018-03-23 2018-08-24 广西科技大学 一种妊娠期及哺乳期妇女用药安全和健康管理系统
KR102490714B1 (ko) * 2018-12-28 2023-01-26 재단법인 아산사회복지재단 Pibf 단백질을 유효성분으로 함유하는 염증성 질환 예방 또는 치료용 약학 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648340A (en) * 1991-10-31 1997-07-15 Barnea; Eytan R. Gestational agents for controlling cell proliferation
US5646003A (en) * 1994-03-23 1997-07-08 Barnea; Eytan R. Preimplantation factor
US6207380B1 (en) * 1997-09-15 2001-03-27 Abbott Laboratories Reagents and methods useful for detecting diseases of the urinary tract
EP1091753B1 (de) * 1998-07-02 2008-01-16 Envision Biomedical Consulting Antiproliferative und antivirale proteine und peptide
AU7854400A (en) * 1999-10-08 2001-04-23 Envision Biomedical Consulting Gestational agents which modulate cell proliferation

Also Published As

Publication number Publication date
ATE357662T1 (de) 2007-04-15
US20040142394A1 (en) 2004-07-22
EP1337850A1 (de) 2003-08-27
DE60127442T2 (de) 2007-11-29
JP2006230407A (ja) 2006-09-07
EP1337850B1 (de) 2007-03-21
JP2004514909A (ja) 2004-05-20
AT410753B (de) 2003-07-25
AU2002224901B2 (en) 2006-11-09
ATA19972000A (de) 2002-12-15
WO2002044734A1 (en) 2002-06-06
JP4025645B2 (ja) 2007-12-26
ES2283461T3 (es) 2007-11-01
AU2490102A (en) 2002-06-11
CA2431837A1 (en) 2002-06-06

Similar Documents

Publication Publication Date Title
DE60129151D1 (de) Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6)
ATE289685T1 (de) Verfahren zum nachweis von karzinomen in solubilisierten zervikalen körperproben
KR100711046B1 (ko) 대장암에 대한 마커로서의 니코틴아미드ｎ―메틸트랜스퍼라아제의 용도
ATE516742T1 (de) Verfahren zur bestimmung der optischen eigenschaften eines mehrschichtigen gewebes
ATE519844T1 (de) Zusammensetzungen und verfahren zur erkennung, diagnose und therapie von hämatologischen malignomen
DE60126592D1 (de) Verfahren, zusammensetzungen und kits zur identifizierung und überwachung von brustkrebs
WO2006127861A3 (en) Diagnosis of diseases and conditions by analysis of histopathologically processed biological samples using liquid tissue preparations
DE60325382D1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
Ntekrash et al. Assessment of complement cleavage in gingival fluid in humans with and without periodontal disease
ATE422671T1 (de) Verfahren zur diagnose von morbus alzheimer
ATE426168T1 (de) Verwendung von asc als marker fur kolorektalkarzinome
DE50311309D1 (de) Vorrichtung und Verfahren zur Erfassung von Vorhofflimmern
ATE357662T1 (de) Verfahren der pibf-konzentrationsbestimmung zur diagnose eines tumors in einem patienten
ATE520987T1 (de) Verfahren zum nachweis und/oder screening zur überwachung eines kolorektalkrebs in einem individuum
ATE472611T1 (de) Verfahren zur diagnose von sepsis durch analyse von cytokine mrna expression
ATE272215T1 (de) Verfahren zur diagnose von sepsis unter bestimmung von ca 19-9
EP2322209A3 (de) Tumorspezifische Oligosaccharid-Epitope und deren Verwendung
ATE366936T1 (de) Zusammensetzungen und verfahren zur verwendung von fibronektin-fragmenten bei krebsdiagnose
WO2005040806A3 (en) Use of protein asc as a marker for breast cancer
RU2007148219A (ru) Способ обнаружения бактерий и тест-набор для их обнаружения
ATE557277T1 (de) Verfahren zur diagnose von endometriose mittels tfpi-2 protein
ATE301943T1 (de) Verfahren zur identifizierung und antropomorphischen klassifizierung für den militärischen sowie zivilen gebrauch
TW200716978A (en) Method
DE69931644D1 (de) Verfahren zur diagnose, feststellung, einstufung, darstellung sowie behandlung gynäkologischer krebserkrankungen
DE602004013355D1 (de) Verwendung des proteins spee als marker für brustkrebs

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee